Researchers created a new algorithm to help choose target HbA1cs for patients with diabetes and compared the results to experts' advice.
Patients who were under age 55 faced a more substantial increase in mortality risk from having diabetes than older patients.
DPP-4 inhibitors associated with lower mortality and cardiac risk than sulfonylureas as add-on therapy, study finds
When added to metformin, DPP-4 inhibitors were associated with reduced risks for all-cause death and stroke but did not appear to alter the risks for myocardial infarction and hospitalization for heart failure relative to sulfonylureas.
This month's quiz asks readers to evaluate a 72-year-old woman with hypertension, type 2 diabetes mellitus, and hyperlipidemia for sharp chest pain that occurs randomly.
Cholesterol markers improved in patients with type 2 diabetes who were assigned to drink wine, and some patients also saw glycemic benefits, a recent study found.
Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea
Patients who took sitagliptin were significantly less likely to have hypoglycemia during Ramadan, according to a systematic review.
A retrospective cohort study used data from the Department of Veterans Affairs to assess both hypertension and blood glucose medication deintensification (i.e., dosage reduction or withdrawal of a drug).
The U.S. Preventive Services Task Force now recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in overweight and obese adults ages 40 to 70 years.